Understanding how to improve immunity against fungal infections
Immunity against fungal infections
This study is looking at how our immune system can be better prepared to fight off fungal infections, especially for people who are more likely to get sick, by figuring out how to boost certain immune cells that help protect us, with the hope of developing a new vaccine to keep everyone safe.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10993669 on NIH RePORTER |
What this research studies
This research investigates the immune responses necessary for developing effective vaccines against fungal infections, particularly in at-risk populations. It focuses on understanding how specific T cells, like CD8+ T cells, can be stimulated to produce protective cytokines that help fight off these infections. By using a mouse model, the researchers aim to identify key immune mechanisms and potential vaccine targets that could lead to better prevention strategies for fungal diseases. The ultimate goal is to create a licensed vaccine that can protect individuals from opportunistic fungal infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for fungal infections, such as those who are immunocompromised.
Not a fit: Patients who are not at risk for fungal infections or those with fully functioning immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from serious fungal infections.
How similar studies have performed: Other research has shown promise in understanding immune responses to fungal infections, but the development of effective vaccines remains largely untested.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Nanjappa, Somashekarappa Gowda — University of Illinois at Urbana-Champaign
- Study coordinator: Nanjappa, Somashekarappa Gowda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.